Ahsan Moosa

Ahsan Moosa

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
CSClaude Steriade
Claude Steriade
AMAhsan Moosa
Ahsan Moosa
SHStephen Hantus
Stephen Hantus
RPRichard A. Prayson
Richard A. Prayson
AAAndreas Alexopoulos
Andreas Alexopoulos
ARAlexander Rae-Grant
Alexander Rae-Grant

2 November 2019 in Epilepsia
Verified
Journal Article
Closed access
PDF file
RMRobert A. McGovern
Robert A. McGovern
AMAhsan Moosa
Ahsan Moosa
LJLara Jehi
Lara Jehi
RBRobyn Busch
Robyn Busch
LFLisa Ferguson
Lisa Ferguson
WBWilliam E. Bingaman
William E. Bingaman

1 November 2017 in Seminars in Pediatric Neurology
Verified
Journal Article
Closed access
AMAhsan Moosa
Ahsan Moosa
EWElaine Wyllie
Elaine Wyllie

6 November 2022 in Epilepsia
Verified
Journal Article
Open access
JHJason K. Hsieh
Jason K. Hsieh
FPFrancesco G. Pucci
Francesco G. Pucci
SSSwetha J. Sundar
Swetha J. Sundar
EKEfstathios Kondylis
Efstathios Kondylis
ASAkshay Sharma
Akshay Sharma
LJLara Jehi
Lara Jehi
Objective: This study was undertaken to better understand the long‐term palliative and disease‐modifying effects of surgical resection beyond seizure freedom, including frequency reduction and both late recurrence and remission, in patients with drug‐resistant epilepsy.Methods: This retrospective database‐driven cohort study included all patients with >9 years of follow‐up at a single high‐volume epilepsy center. We included patients who underwent lobectomy, multilobar resection, or lesionectomies for drug‐resistant epilepsy; we excluded patients who underwent hemispherectomies. Our main outcomes were (1) reduction in frequency of disabling seizures (at 6 months, each year up to 9 years postoperatively, and at last follow‐up), (2) achievement of seizure remission (>6 months, >1 year, and longest duration), and (3) seizure freedom at last follow‐up.Results: We included 251 patients; 234 (93.2%) achieved 6 months and 232 (92.4%) experienced 1 year of seizure freedom. Of these, the average period of seizure freedom was 10.3 years. A total of 182 (72.5%) patients were seizure‐free at last follow‐up (defined as >1 year without seizures), with a median 11.9 years since remission. For patients not completely seizure‐free, the mean seizure frequency reduction at each time point was 76.2%, and ranged from 66.6% to 85.0%. Patients decreased their number of antiseizure medications on average by .58, and 53 (21.2%) patients were on no antiseizure medication at last follow‐up. Nearly half (47.1%) of those seizure‐free at last follow‐up were not seizure‐free immediately postoperatively.Significance: Patients who continue to have seizures after resection often have considerable reductions in seizure frequency, and many are able to achieve seizure freedom in a delayed manner.

29 June 2012 in Journal of Child Neurology
Verified
Journal Article
Closed access
PDF file
AMAhsan Moosa
Ahsan Moosa
ETElias I. Traboulsi
Elias I. Traboulsi
JRJanet Reid
Janet Reid
LPLourdes Prieto
Lourdes Prieto
RMRocio Moran
Rocio Moran
NFNeil R. Friedman
Neil R. Friedman
Mutations in the smooth muscle–specific isoform of α-actin (ACTA2) cause vascular smooth muscle dysfunction leading to aortic aneurysm and moyamoya syndrome. A unique R179H mutation in ACTA2 has been reported to result in widespread smooth muscle dysfunction affecting vascular and extravascular smooth muscles. We report a 7-year-old girl with an ACTA2 R179H mutation manifesting with neonatal seizures due to multifocal infarcts, asymmetric motor deficits, global developmental delay, spasticity, congenital bilateral mydriasis, and a large patent ductus arteriosus. Serial magnetic resonance imaging (MRI) of the brain over 7 years showed diffuse supratentorial white matter abnormalities consistent with a progressive leukoencephalopathy. Magnetic resonance angiography of the cerebral vessels showed stenosis in the terminal portion of the bilateral internal carotid arteries with fusiform dilation of the proximal segment. Neonatal onset of neurologic symptoms in ACTA2 mutations has not been previously reported. R179H mutation in ACTA2 represents the severe end of the disease spectrum.

1 January 2013
Verified
Book Chapter
Closed access
AMAhsan Moosa
Ahsan Moosa
EWElaine Wyllie
Elaine Wyllie